ICUI
Icu Medical Inc/de Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$163.78Close
$4.0BMarket cap
$115.45 – $187.2652-week range
Nov 5, 2026Next report · after the close
Highlights
Cautions
- Trend not confirmed 7 of 8 conditions · under the 50-day
- Distribution down-day volume 1.9× up-day volume over 50 sessions
- Earnings shrinking EPS −47% year on year
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
13%
1wk
down 1.7%
price change
1mo
up 2.0%
price change
12-month return
up 37%
market up 11% ·
its own up 28%
F-score
6 / 9
Mixed
Altman Z
2.29
Moderate risk
P/E
5523.8×
price / earnings
PEG
—
P/E / EPS growth
P/B
1.9×
price / book
Earnings yield
up 0.9%
EBIT / enterprise value
Cheaper than
47%
of the market · around average
Revenue growth
down 6%
year on year
EPS growth
down 47%
latest quarter
Sales growth
up 1%
latest quarter · +13 pts
ROE
0%
return on equity
Free cash margin
up 4%
$91.8M FCF
D/E
0.60
long-term debt / equity
Net debt / EBITDA
3.9×
Interest cover
0.5×EBIT / interest
Piotroski tests
- short-term liquidity weakened
- issued more shares
- assets working less efficiently
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- gross margin widened
Repair signals
- Long-term debt down 17% ($1.5B → $1.3B)
- Gross margin 34.6% → 36.8%
Trade setup
ATR%
3.1%
$5.05 a day · 2×ATR $153.67
RS
71 / 99
vs the universe
Trend
7 / 8
under the 50-day
Relative volume
0.9×
vs 50-day average
Up/down volume
0.52
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 7 of 8
- Price above the 50-day average: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Operating profit does not cover interest Earnings before interest cover the interest bill 0.5 times. Below 0.5× the debt is being serviced from something other than operations.
- Revenue shrinking Revenue fell 6.3% over the year, from $2.4B to $2.2B.
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026+10% vs market2 sessions after results
Financials
- Gross 37%
- Net 0%
- Free cash 4%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $2.3B | $2.3B | $2.4B | $2.2B |
| Gross margin | 36% | 37% | 31% | 33% | 35% | 37% |
| Operating income | $98.2M | $123.2M | -$42.9M | $22.8M | $43.0M | $42.8M |
| Net income | $86.9M | $103.1M | -$74.3M | -$29.7M | -$117.7M | $732,000 |
| Net margin | 7% | 8% | -3% | -1% | -5% | 0% |
| Earnings per share | $4.02 | $4.74 | -$3.11 | -$1.23 | -$4.83 | $0.03 |
| Free cash flow | $130.7M | $199.0M | -$152.4M | $82.3M | $124.7M | $91.8M |
| Free cash margin | 10% | 15% | -7% | 4% | 5% | 4% |
| Cash | $396.1M | $552.8M | $208.8M | $254.2M | $308.6M | $308.0M |
| Long-term debt | — | $0 | $1.6B | $1.6B | $1.5B | $1.3B |
| Shareholders' equity | $1.5B | $1.6B | $2.1B | $2.1B | $2.0B | $2.1B |
| Shares outstanding | 21.06m | 21.28m | 23.99m | 24.14m | 24.52m | 24.69m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Feb 19, 2026 | Annual ↗ | Dec 31, 2025 | 50d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Aug 7, 2025 | Quarterly ↗ | Jun 30, 2025 | 38d |
| May 8, 2025 | Quarterly ↗ | Mar 31, 2025 | 38d |
| Feb 27, 2025 | Annual ↗ | Dec 31, 2024 | 58d |
| Nov 12, 2024 | Quarterly ↗ | Sep 30, 2024 | 43d |
| Aug 7, 2024 | Quarterly ↗ | Jun 30, 2024 | 38d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Feb 27, 2024 | Annual ↗ | Dec 31, 2023 | 58d |
| Nov 6, 2023 | Quarterly ↗ | Sep 30, 2023 | 37d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 6, 2026 | Results ↗ |
| May 18, 2026 | Charter or bylaws · Shareholder vote ↗ |
| May 7, 2026 | Results ↗ |
| Feb 20, 2026 | Director or officer change ↗ |
| Feb 19, 2026 | Results ↗ |
| Nov 6, 2025 | Results ↗ |
| Aug 7, 2025 | Results ↗ |
| May 14, 2025 | Director or officer change · Shareholder vote ↗ |
| May 8, 2025 | Results ↗ |
| Feb 27, 2025 | Results ↗ |
| Nov 12, 2024 | Results ↗ |
| Oct 2, 2024 | Director or officer change ↗ |